This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its trifluoromethyl group enhances the biological activity and metabolic stability of the resulting drugs, making it valuable in the development of anti-inflammatory, antimicrobial, and anticancer agents. Additionally, it is employed in organic synthesis to construct complex molecules, particularly in the preparation of quinoline-based compounds with potential therapeutic applications. Its unique structure also makes it a useful building block in the creation of materials with specific electronic or optical properties.